Adam's Blogroll: click through to the author's blog
As a journal editor, are you tired of hearing the same excuses from authors who are facing allegations of problematic data? If so, you’re not alone. Recently, an editor of the journal Oncogene co-authored an editorial in the journal listing the types of excuses he often hears — and why none of them is valid. […]
The post “My dog ate the data:” Eight excuses journal editors hear appeared first on Retraction Watch.
Posted by in nature publishing group, oncogene (journal), uk retractions, united states
When journals learn papers are problematic, how long does it take them to act? We recently had a chance to find out as part of our continuing coverage of the case of Anil Jaiswal at the University of Maryland, who’s retracted 15 papers (including two new ones we recently identified), and has transitioned out of […]
The post A university asked for numerous retractions. Eight months later, three journals have done nothing. appeared first on Retraction Watch.
Posted by in American Association for Cancer Research, biochem biophys research comm, cancer biology, cancer research, Chemico-Bio Interactions, clinical cancer research, company of biologists, duplication retractions, elsevier, FEBS J, free radical biology medicine, freely available, image manipulation, jbc retractions, journal of cell science, misconduct investigations, molecular cancer therapeutics, nature publishing group, oncogene (journal), society journal retractions, united states, wiley, wiley retractions
Here’s a rather odd case: When readers raised issues about some of the images in a 2008 cancer paper, the authors issued a correction last year. But when readers asked additional questions about the corrected images, the authors decided to retract the paper entirely, along with its correction. Both the original and corrected versions were questioned on […]
The post Huh? Cancer paper gets retracted because of its correction appeared first on Retraction Watch.
Robert Weinberg, a prominent cancer researcher at the Whitehead Institute, issued a correction to a paper in Oncogene in May, fixing two errors missed during proofing. We found this one a little late, obviously. It also appears to be a relatively minor correction, not one that appears worthy of retraction. We’ve gotten feedback from readers […]
The post Cancer research pioneer Robert Weinberg corrected Oncogene paper appeared first on Retraction Watch.
A highly cited cancer researcher at MD Anderson has notched three major corrections, all associated with problems in figures. One note cites “human error” as the cause. Bharat Aggarwal is the last author on all three papers. He is now up to six corrections, two unexplained withdrawals, and two Expressions of Concern. He’s also threatened to sue us in the past, […]
The post MD Anderson researcher Aggarwal up to six corrections appeared first on Retraction Watch.
Oncogene is retracting a 2010 paper on the molecular details of breast cancer cells as they undergo metastasis following an investigation that discovered the first author had committed misconduct. The thing is, the investigation concluded in 2012, and the paper — “miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion […]
The post Oncogene to retract breast cancer paper following years-old misconduct investigation appeared first on Retraction Watch.
